BIIB - Biogen Inc
IEX Last Trade
204.63
-0.190 -0.093%
Share volume: 878,984
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$204.82
-0.19
-0.09%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-25 | 2023-02-15 | 2023-04-25 | 2023-07-25 | 2023-11-08 | 2024-02-14 | 2024-04-24 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 24.854 B | 24.554 B | 24.598 B | 25.157 B | 28.193 B | 26.845 B | 26.568 B | 26.804 B | |
| Current Assets | 9.766 B | 9.791 B | 9.763 B | 10.432 B | 8.454 B | 6.859 B | 6.756 B | 7.109 B | |
| Inventories | 1.375 B | 1.344 B | 1.281 B | 1.334 B | 2.982 B | 2.527 B | 2.517 B | 2.506 B | |
| Other Current Assets | 1.496 B | 1.418 B | 1.412 B | 895.900 M | 974.100 M | 1.182 B | 1.165 B | 615.300 M | |
| Short Term Investments | 1.496 B | 1.418 B | 1.412 B | 895.900 M | 974.100 M | 1.182 B | 1.165 B | 615.300 M | |
| Total Receivables | 1.984 B | 2.136 B | 2.028 B | 2.124 B | 2.210 B | 2.100 B | 2.000 B | 2.078 B | |
| Current Cash | 4.911 B | 4.893 B | 5.041 B | 6.078 B | 2.288 B | 1.050 B | 1.074 B | 1.909 B | |
| Total Non-current Assets | 15.088 B | 14.763 B | 14.836 B | 14.725 B | 19.739 B | 19.986 B | 19.811 B | 19.696 B | |
| Property Plant Equipment | 3.266 B | 3.299 B | 3.301 B | 3.307 B | 3.302 B | 3.310 B | 3.275 B | 3.249 B | |
| Other Assets | 1.613 B | 1.529 B | 1.381 B | 1.105 B | 754.600 M | 745.000 M | 697.600 M | 681.500 M | |
| Intangible Assets | 2.009 B | 1.850 B | 1.813 B | 1.776 B | 7.345 B | 8.363 B | 8.285 B | 8.233 B | |
| Goodwill | 5.741 B | 5.749 B | 5.752 B | 5.754 B | 6.808 B | 6.219 B | 6.227 B | 6.227 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 24.854 B | 24.554 B | 24.598 B | 25.157 B | 28.193 B | 26.845 B | 26.568 B | 26.804 B | |
| Total liabilities | 12.079 B | 11.156 B | 10.802 B | 10.690 B | 13.709 B | 12.045 B | 11.355 B | 10.915 B | |
| Total current liabilities | 3.926 B | 3.273 B | 3.015 B | 3.187 B | 5.022 B | 3.434 B | 3.223 B | 3.108 B | |
| Accounts Payable | 383.200 M | 491.500 M | 491.200 M | 445.400 M | 440.100 M | 403.300 M | 387.000 M | 354.500 M | |
| Other liabilities | 1.198 B | 944.200 M | 935.500 M | 776.900 M | 747.900 M | 781.100 M | 777.100 M | 556.700 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 500.000 M | 150.000 M | 250.000 M | 0.000 | |
| Long term debt | 6.279 B | 6.281 B | 6.283 B | 6.285 B | 6.786 B | 6.788 B | 6.290 B | 6.292 B | |
| Other liabilities | 1.198 B | 944.200 M | 935.500 M | 776.900 M | 747.900 M | 781.100 M | 777.100 M | 556.700 M | |
| Minority interest | -8.700 M | -9.500 M | -9.600 M | -6.400 M | -4.100 M | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 12.776 B | 13.398 B | 13.797 B | 14.467 B | 14.484 B | 14.799 B | 15.213 B | 15.889 B | |
| Common stock | 144.400 M | 143.800 M | 144.400 M | 144.700 M | 144.800 M | 144.900 M | 145.200 M | 145.600 M | |
| Retained earnings | 15.916 B | 16.467 B | 16.854 B | 17.446 B | 17.378 B | 17.628 B | 18.021 B | 18.605 B |